Results 41 to 50 of about 4,051,537 (300)

Serotonin Syndrome in an Adolescent as a Result of Suicide with Fluoxetine [PDF]

open access: yesAsia Pacific Journal of Medical Toxicology, 2022
Introduction: The overdose of selective serotonin reuptake inhibitor rarely causes death or serious sequelae. While it may be mildlysymptomatic or asymptomatic at doses up to 30 times the daily therapeutic dose, higher doses may cause drowsiness, tremor ...
Raif Yıldız   +3 more
doaj   +1 more source

Serotonergic agents and linezolid: Impact of exposure to more than one agent concomitantly on risk of adverse effects

open access: yesAntimicrobial Stewardship & Healthcare Epidemiology, 2023
Background: The off-target effects linezolid have the potential to cause serotonin syndrome when given in conjunction with serotonergic agents. Despite package insert labeling as a contraindication, several postmarketing studies have demonstrated a low ...
Xuping Yan   +5 more
doaj   +1 more source

Association of Linezolid With Risk of Serotonin Syndrome in Patients Receiving Antidepressants

open access: yesJAMA Network Open, 2022
This cohort study examines the incidence of serotonin syndrome among patients receiving linezolid treatment while taking an antidepressant compared with those not taking an antidepressant.
A. Bai   +4 more
semanticscholar   +1 more source

Serotonin syndrome [PDF]

open access: yesEmergency Medicine Journal, 2007
Serotonin syndrome is an under-reported and under-recognised condition that occurs on administration of selective serotonin re-uptake inhibitors alone, or in combination with other medication known to increase levels of 5-hydroxytryptamine. This case report demonstrates signs and symptoms associated with their overdose and illustrates the importance of
Charlotte Elizabeth, Evans   +1 more
openaire   +3 more sources

Serotonin syndrome induced by overdose of atomoxetine alone in a patient with attention‐deficit hyperactivity disorder: A case report

open access: yesPCN Reports, 2022
Background Serotonin syndrome is characterized by mental status changes, autonomic hyperactivity, and neuromuscular abnormalities. This syndrome results from various medications that engender serotonergic overactivity.
Fumika Sato   +6 more
doaj   +1 more source

Famotidine-induced reversal of meperidine-related serotonin syndrome: a case report [PDF]

open access: yesKorean Journal of Anesthesiology, 2017
Serotonin syndrome is an unexpected fatal adverse event related to serotonergic medication. This case report is the first report describing the possible treatment effect of famotidine on serotonin syndrome.
Soohyun Joe   +5 more
doaj   +1 more source

Ruminococcus gnavus plays a pathogenic role in diarrhea-predominant irritable bowel syndrome by increasing serotonin biosynthesis.

open access: yesCell Host and Microbe, 2022
Diarrhea-predominant irritable bowel syndrome (IBS-D), a globally prevalent functional gastrointestinal (GI) disorder, is associated with elevated serotonin that increases gut motility.
L. Zhai   +20 more
semanticscholar   +1 more source

Pinpointing brainstem mechanisms responsible for autonomic dysfunction in Rett syndrome: therapeutic perspectives for 5-HT1A agonists [PDF]

open access: yes, 2014
Rett syndrome is a neurological disorder caused by loss of function of methyl-CpG-binding protein 2 (MeCP2). Reduced function of this ubiquitous transcriptional regulator has a devastating effect on the central nervous system.
Newman-Tancredi, Adrian   +8 more
core   +1 more source

Serotonin syndrome in two COVID-19 patients treated with lopinavir/ritonavir

open access: yesJournal of Neurological Sciences, 2020
Highlights • Two cases of Serotonin syndrome (SS) in COVID-19 patients are presented.• Lopinavir/ritonavir (LPV/r) have been widely used during the COVID-19 pandemic.• LPV/r with duloxetine and lithium triggered SS in patient 1.• LPV/r with risperidone ...
Miguel Mas Serrano   +6 more
semanticscholar   +1 more source

Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI)

open access: yesJA Clinical Reports, 2019
Background Serotonin syndrome is a rare but potentially severe disease, which is caused by hyperstimulation of serotonin receptors in the central nervous system.
Junko Takata   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy